These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 16814450
1. Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study. Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS, Maeda MY, Longatto-Filho A, Syrjänen KJ. Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):239-46. PubMed ID: 16814450 [Abstract] [Full Text] [Related]
2. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study. Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. J Med Screen; 2008 Aug; 15(2):97-104. PubMed ID: 18573778 [Abstract] [Full Text] [Related]
3. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Aug; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]
7. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC. Eur J Obstet Gynecol Reprod Biol; 2005 Jul 01; 121(1):104-9. PubMed ID: 15950365 [Abstract] [Full Text] [Related]
8. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV. Cancer Causes Control; 2003 Aug 01; 14(6):505-12. PubMed ID: 12948281 [Abstract] [Full Text] [Related]
9. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400 [Abstract] [Full Text] [Related]
10. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. JAMA; 2001 Dec 26; 286(24):3106-14. PubMed ID: 11754676 [Abstract] [Full Text] [Related]
11. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153 [Abstract] [Full Text] [Related]
12. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa. Adam Y, McIntyre JA, De Bruyn G. S Afr Med J; 2012 Nov 22; 103(1):34-9. PubMed ID: 23237122 [Abstract] [Full Text] [Related]
15. Cytology versus HPV testing for cervical cancer screening in the general population. Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M. Cochrane Database Syst Rev; 2017 Aug 10; 8(8):CD008587. PubMed ID: 28796882 [Abstract] [Full Text] [Related]